Raloxifene Evista

a. Raloxifene is approved for the prevention of osteoporosis. When used at 60 mg per day, raloxifene demonstrates modest increases (1.5-2% in 24 months) in bone density. This increase in density is half of that seen in those patients receiving ERT. Raloxifene also results in a beneficial effect on the lipid profile similar to that seen with estrogen.

b. Raloxifene lacks breast stimulation properties, and it may provide a protective effect against breast cancer, resulting in a 50-70% reduction in breast cancer risk.

c. Minor common side effects include hot flashes and leg cramps. Serious side effects include an increased risk of venous thromboembolism.

Breaking Bulimia

Breaking Bulimia

We have all been there: turning to the refrigerator if feeling lonely or bored or indulging in seconds or thirds if strained. But if you suffer from bulimia, the from time to time urge to overeat is more like an obsession.

Get My Free Ebook


Post a comment